As STAT3 has been shown to interact with VEGF-R1/2 in CLL [32], it is well characterized that VEGF activation is associated with Jak-tyrosine kinase activation [12-16]. This evidence concerns the gene FLT1 and B-cell chronic lymphocytic leukemia.